Cargando…

B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling

Modulation of T-cell responses has played a key role in treating cancers and autoimmune diseases. Therefore, understanding how different receptors on T cells impact functional outcomes is crucial. The influence of B7-H7 (HHLA2) and CD28H (TMIGD2) on T-cell activation remains controversial. Here we e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rieder, Sadiye Amcaoglu, Wang, Jingya, White, Natalie, Qadri, Ariful, Menard, Catherine, Stephens, Geoffrey, Karnell, Jodi L., Rudd, Christopher E., Kolbeck, Roland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166953/ https://www.ncbi.nlm.nih.gov/pubmed/32005952 http://dx.doi.org/10.1038/s41423-020-0361-7

Ejemplares similares

In or out of control: Modulating regulatory T cell homeostasis and function with immune checkpoint pathways
por: Abdeladhim, Maha, et al.
Publicado: (2022)

CD28 family of receptors inter-connect in the regulation of T-cells
por: Krueger, Janna, et al.
Publicado: (2017)

Evaluation of ultra-low input RNA sequencing for the study of human T cell transcriptome
por: Wang, Jingya, et al.
Publicado: (2019)

KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
por: Li, Yang, et al.
Publicado: (2022)

HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival
por: Koirala, Pratistha, et al.
Publicado: (2016)

Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma
por: Zhu, Ziwen, et al.
Publicado: (2018)

Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways
por: Wang, Feng, et al.
Publicado: (2023)

Regulation of HHLA2 expression in kidney cancer and myeloid cells
por: Shigemura, Tomonari, et al.
Publicado: (2023)

Novel immune scoring dynamic nomograms based on B7-H3, B7-H4, and HHLA2: Potential prediction in survival and immunotherapeutic efficacy for gallbladder cancer
por: Lv, Chao, et al.
Publicado: (2022)

TCR and CD28 activate the transcription factor NF-κB in T-cells via distinct adaptor signaling complexes
por: Thaker, Youg Raj, et al.
Publicado: (2015)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment
por: Luo, Min, et al.
Publicado: (2021)

HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma
por: Xu, Yituo, et al.
Publicado: (2021)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]
Publicado: (2021)

Overexpression and Role of HHLA2, a Novel Immune Checkpoint, in Colorectal Cancer
por: Kula, Agnieszka, et al.
Publicado: (2023)

The Loss of PTEN Allows TCR αβ Lineage Thymocytes to Bypass IL-7 and Pre-TCR–mediated Signaling
por: Hagenbeek, Thijs J., et al.
Publicado: (2004)

HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2019)

HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer
por: Xu, Guocai, et al.
Publicado: (2021)

HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2022)

The Interplay of IL-21 and BAFF in the Formation and Maintenance of Human B Cell Memory
por: Karnell, Jodi L., et al.
Publicado: (2012)

Binding of Staphylococcal Enterotoxin B (SEB) to B7 Receptors Triggers TCR- and CD28-Mediated Inflammatory Signals in the Absence of MHC Class II Molecules
por: Kunkl, Martina, et al.
Publicado: (2021)

Prognostic Significance of Potential Immune Checkpoint Member HHLA2 in Human Tumors: A Comprehensive Analysis
por: Wang, Ben, et al.
Publicado: (2019)

HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis
por: Boor, Patrick P. C., et al.
Publicado: (2020)

Prognostic value of HHLA2 expression in solid tumors: A meta-analysis based on the Chinese population
por: Zhang, Chuanmeng, et al.
Publicado: (2021)

HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer
por: Yang, Zeng, et al.
Publicado: (2022)

Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma
por: Ding, Lin, et al.
Publicado: (2022)

Increased co-expression of stromal HHLA2 and fibroblast activation protein in upper tract urothelial carcinoma
por: Nishihara, Daisaku, et al.
Publicado: (2023)

Distinct and common expression of receptors for inflammatory mediators in vagal nodose versus jugular capsaicin-sensitive/TRPV1-positive neurons detected by low input RNA sequencing
por: Wang, Jingya, et al.
Publicado: (2017)

Fbw7 and Usp28 – enemies and allies
por: Taranets, Lyudmyla, et al.
Publicado: (2015)

The LIN28/let-7 Pathway in Cancer
por: Balzeau, Julien, et al.
Publicado: (2017)

Immune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal
por: Badawi, Ahmed H, et al.
Publicado: (2014)

Expedient Synthesis of Lupulones and Their Derivatization to 2,8‐7H‐Dihydrochromen‐7‐ones
por: Decuyper, Lena, et al.
Publicado: (2020)

HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
por: Jing, Chu-Yu, et al.
Publicado: (2019)

Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
por: Chen, Lujun, et al.
Publicado: (2019)

Coexpression of HHLA2 and PD-L1 on Tumor Cells Independently Predicts the Survival of Spinal Chordoma Patients
por: Xia, Chao, et al.
Publicado: (2022)

HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma
por: Huang, Fu-xue, et al.
Publicado: (2022)

HHLA2 promotes tumor progression by long non-coding RNA H19 in human gallbladder cancer
por: Zhang, Yizhou, et al.
Publicado: (2022)

PKC-theta-mediated signal delivery from the TCR/CD28 surface receptors
por: Isakov, Noah, et al.
Publicado: (2012)

In silico Analysis of TCR Vβ7 of Two Patients with Type 1 Diabetes Mellitus
por: Zhou, Jianwei, et al.
Publicado: (2013)

Selective Inhibition of USP7
por: Menard, Robert, et al.
Publicado: (2012)

IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE
por: Wang, Shu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t3om4dr4ip7ka67crhsuj8a36f